Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below 12 months to the week close of 2026-10-23

Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 23, 2022 SYRE A 130,000 · · 130,000 Direct · Acquired
Feb. 17, 2022 SYRE A 180,000 · · 180,000 Direct · Acquired
Feb. 17, 2021 SYRE A 160,000 · · 160,000 Direct · Acquired
Feb. 14, 2020 SYRE A 100,000 · · 100,000 Direct · Acquired
March 6, 2019 SYRE A 36,000 · · 36,000 Direct · Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Aug. 23, 2022 SYRE Employee Stock Option (right to buy) Common Stock (130,000) $0.68 Aug. 22, 2032 130,000 Acquired
Feb. 17, 2022 SYRE Employee Stock Option (right to buy) Common Stock (180,000) $3.17 Feb. 16, 2032 180,000 Acquired
Feb. 17, 2021 SYRE Employee Stock Option (right to buy) Common Stock (160,000) $7.35 Feb. 16, 2031 160,000 Acquired
Feb. 14, 2020 SYRE Employee Stock Option (right to buy) Common Stock (100,000) $8.15 Feb. 13, 2030 100,000 Acquired
March 6, 2019 SYRE Employee Stock Option (right to buy) Common Stock (36,000) $8.06 March 5, 2029 36,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
March 8, 2019 SYRE Employee Stock Option (right to buy)→ Common Stock (55,000) 55,000 Direct
March 8, 2019 SYRE Employee Stock Option (right to buy)→ Common Stock (80,000) 80,000 Direct
March 8, 2019 SYRE Employee Stock Option (right to buy)→ Common Stock (72,000) 72,000 Direct

Compensation (DEF 14A)

10

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $435,000 · · · $174,000 · $13,323 $1,087,882
2021 $410,000 · · · $200,000 · $16,940 $1,449,436
2020 $370,000 · · · $148,000 · $20,349 $1,246,319

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.